Quarterly report pursuant to Section 13 or 15(d)

PRIOR PERIOD RESTATEMENT (Tables)

v3.10.0.1
PRIOR PERIOD RESTATEMENT (Tables)
6 Months Ended
May 31, 2018
Condensed Financial Statements [Table Text Block]
  Quarter ended
  May 31, 2017
     
  Prior to  
  Restatement Restated
  $ $
Consolidated Balance Sheet:    
Secured convertible debentures, net of deferred financing costs 1,669,359 1,433,593
Derivative liabilities 381,671 579,775
Total Liabilities 2,445,674 2,408,012
Accumulated deficit ( 29,159,079) ( 29,120,169)
Total Stockholders' Deficiency ( 1,530,046) ( 1,491,136)
     
Consolidated Statement of Operations and Comprehensive Loss Three months ended
  May 31, 2017
Foreign currency translation (gain) ( 20,445) ( 20,633)
Selling, general and administration 587,581 525,696
Total Operating Expenses 580,286 518,213
Loss from Operations ( 535,287) ( 473,214)
Change in fair value of derivative liabilities 86,000 24,052
Accretion - ( 86,609)
Loss before Income Taxes ( 595,104) ( 681,588)
Net Loss ( 595,104) ( 681,588)
Comprehensive Loss ( 595,461) ( 681,945)
Loss per share-basic and diluted (0.010) (0.012)
     
Consolidated Statement of Operations and Comprehensive Loss Six months ended
  May 31, 2017
Foreign currency translation (gain) ( 7,289) ( 6,811)
Selling, general and administration 1,111,194 1,004,856
Total Operating Expenses 1,129,027 1,023,167
Loss from Operations ( 1,064,706) ( 958,846)
Change in fair value of derivative liabilities 507,379 595,700
Accretion - ( 155,271)
Loss before Income Taxes ( 860,466) ( 821,556)
Net Loss ( 860,466) ( 821,556)
Comprehensive Loss ( 838,670) ( 799,760)
Loss per share-basic and diluted (0.020) (0.014)
     
Consolidated Statement of Cash Flows Six months ended
  May 31, 2017
Net loss ( 860,466) ( 821,556)
Foreign currency translation gain ( 7,289) ( 6,811)
Accretion 106,338 155,271
Change in fair value of derivative liabilities ( 507,379) ( 595,700)
Net cash used in operating activities ( 1,031,024) ( 1,031,024)